Abilify and Amantadine hydrochloride drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Abilify (aripiprazole) and Amantadine hydrochloride (amantadine hydrochloride). Common drug interactions include acute coronary syndrome among females and neuroleptic malignant syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Abilify and Amantadine hydrochloride. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.
What is Amantadine hydrochloride?
Amantadine hydrochloride has active ingredients of amantadine hydrochloride. It is often used in parkinson's disease. eHealthMe is studying from 2,398 Amantadine hydrochloride users. Check the latest studies of Amantadine hydrochloride.
14 people who take Abilify and Amantadine hydrochloride together, and have interactions are studied.

What are the common drug interactions of Abilify and Amantadine Hydrochloride, by gender? *:
female:
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Arteriosclerosis (thickening and hardening of arteries)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Malaise (a feeling of general discomfort or uneasiness)
- Pallor
- Respiratory distress (difficulty in breathing)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Tooth disorder (tooth disease)
male:
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Pneumonia
- Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
- Intestinal obstruction
- Therapeutic response unexpected
- Vomiting
- Akathisia (a movement disorder characterized by a feeling of inner restlessness)
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Renal impairment (severely reduced kidney function)
- Respiratory failure (inadequate gas exchange by the respiratory system)
What are the common drug interactions of Abilify and Amantadine Hydrochloride, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Respiratory distress (difficulty in breathing)
40-49:
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Pneumonia
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Renal impairment (severely reduced kidney function)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Death
50-59:
- Arteriosclerosis (thickening and hardening of arteries)
- Colitis (inflammation of colon)
- Intestinal obstruction
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
60+:
- Akathisia (a movement disorder characterized by a feeling of inner restlessness)
- Blood glucose decreased
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
- Malaise (a feeling of general discomfort or uneasiness)
- Pallor
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Tooth disorder (tooth disease)
- Vomiting
What are the existing conditions these people have? *
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 21.43%
- Bipolar Disorder (mood disorder): 3 people, 21.43%
- Stress And Anxiety: 1 person, 7.14%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 7.14%
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 7.14%
- Hallucinations (sensations that appear real but are created by your mind): 1 person, 7.14%
- Hallucination, Auditory (perceiving sounds without auditory stimulus): 1 person, 7.14%
- Gaze Palsy (disorders affecting the ability to move both eyes in the same direction): 1 person, 7.14%
- Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 1 person, 7.14%
- Delusion (a false belief or opinion): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and Amantadine hydrochloride?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Abilify (101,454 reports)
- Amantadine hydrochloride (2,398 reports)
Browse all drug interactions of Abilify and Amantadine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Amantadine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abilify and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Amantadine hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Yang Y, Teja S, Baig K, "Bilateral corneal edema associated with amantadine", Canadian Medical Association Journal, 2015 Oct .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cattoni J, Parekh R, "Acute respiratory distress syndrome: A rare presentation of amantadine toxicity", The American journal of case reports, 2012 Jan .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Yang Y, Teja S, Baig K, "Bilateral corneal edema associated with amantadine", Canadian Medical Association Journal, 2015 Oct .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cattoni J, Parekh R, "Acute respiratory distress syndrome: A rare presentation of amantadine toxicity", The American journal of case reports, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole and amantadine hydrochloride (the active ingredients of Abilify and Amantadine hydrochloride, respectively), and Abilify and Amantadine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lyrica cause Haemochromatosis? - now
- Drug interactions of Vivelle and Valium - 23 seconds ago
- Drug interactions of Motrin and Tequin - 23 seconds ago
- Hyzaar vs. Altace, side effect and effectiveness comparison - 28 seconds ago
- Drug interactions of Amlodipine and Suprax - 42 seconds ago
- Could Nexium cause Dissociation? - 45 seconds ago
- Zorvolex vs. Prednisone, side effect and effectiveness comparison - 46 seconds ago
- Fluid Overload and Hyperkalemia - a minute ago
- Could Lyrica cause B-Lymphocyte Count Decreased? - a minute ago
- Seizures and Nephropathy - a minute ago